tiprankstipranks
Trending News
More News >
Giant Biogene Holding Co. Ltd. (HK:2367)
:2367
Hong Kong Market
Advertisement

Giant Biogene Holding Co. Ltd. (2367) Ratios

Compare
4 Followers

Giant Biogene Holding Co. Ltd. Ratios

HK:2367's free cash flow for Q4 2024 was ¥0.82. For the 2024 fiscal year, HK:2367's free cash flow was decreased by ¥ and operating cash flow was ¥0.40. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
7.66 7.79 9.03 1.09 1.05
Quick Ratio
7.29 7.42 8.38 1.07 1.02
Cash Ratio
4.82 4.72 4.74 1.04 0.17
Solvency Ratio
2.28 2.47 3.42 0.12 0.39
Operating Cash Flow Ratio
1.10 3.10 3.32 0.10 0.38
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 5.48B¥ 3.53B¥ 2.24B¥ 579.92M¥ 90.99M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 0.00 0.00
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 0.00 0.00
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.13 1.14 1.11 7.75 5.79
Debt Service Coverage Ratio
0.00 13.24K 49.01K 0.00 0.00
Interest Coverage Ratio
0.00 14.86K 56.51K 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 <0.01 <0.01 0.00 0.00
Net Debt to EBITDA
-1.74 -1.41 -1.10 -7.57 -0.55
Profitability Margins
Gross Profit Margin
82.09%83.63%84.39%87.24%84.59%
EBIT Margin
41.13%49.52%49.81%62.67%68.16%
EBITDA Margin
41.70%50.49%50.98%60.47%56.62%
Operating Profit Margin
41.68%47.24%50.19%58.91%54.75%
Pretax Profit Margin
44.37%49.52%49.81%62.67%81.75%
Net Profit Margin
37.23%41.19%42.38%53.34%69.42%
Continuous Operations Profit Margin
37.22%41.09%42.36%53.34%69.42%
Net Income Per EBT
83.91%83.19%85.08%85.12%84.92%
EBT Per EBIT
106.46%104.82%99.25%106.38%149.31%
Return on Assets (ROA)
25.66%29.19%31.93%10.51%31.17%
Return on Equity (ROE)
31.54%33.28%35.36%81.44%180.45%
Return on Capital Employed (ROCE)
32.06%37.48%41.53%88.35%136.59%
Return on Invested Capital (ROIC)
26.87%31.09%35.31%75.20%115.99%
Return on Tangible Assets
25.68%29.24%32.00%10.52%31.28%
Earnings Yield
3.98%4.59%3.46%3.91%3.71%
Efficiency Ratios
Receivables Turnover
34.48 0.00 0.00 0.00 0.00
Payables Turnover
3.46 4.33 6.76 8.39 5.74
Inventory Turnover
3.19 2.88 2.01 2.22 2.84
Fixed Asset Turnover
4.70 4.95 4.29 4.65 4.24
Asset Turnover
0.69 0.71 0.75 0.20 0.45
Working Capital Turnover Ratio
1.06 1.20 1.66 4.38 2.53
Cash Conversion Cycle
19.46 42.59 127.77 121.17 65.10
Days of Sales Outstanding
10.59 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
114.37 126.79 181.80 164.67 128.67
Days of Payables Outstanding
105.50 84.20 54.03 43.49 63.58
Operating Cycle
124.96 126.79 181.80 164.67 128.67
Cash Flow Ratios
Operating Cash Flow Per Share
0.92 1.68 0.95 0.71 0.84
Free Cash Flow Per Share
0.76 1.45 0.80 0.60 0.76
CapEx Per Share
0.17 0.23 0.16 0.11 0.08
Free Cash Flow to Operating Cash Flow
0.82 0.86 0.84 0.84 0.91
Dividend Paid and CapEx Coverage Ratio
5.58 7.21 1.79 0.26 10.93
Capital Expenditure Coverage Ratio
5.58 7.21 6.08 6.23 10.93
Operating Cash Flow Coverage Ratio
137.52 603.68 360.26 0.00 0.00
Operating Cash Flow to Sales Ratio
0.17 0.47 0.39 0.45 0.70
Free Cash Flow Yield
1.38%4.48%2.69%2.74%3.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
25.14 21.80 28.90 25.60 26.95
Price-to-Sales (P/S) Ratio
9.90 8.98 12.25 13.65 18.71
Price-to-Book (P/B) Ratio
7.29 7.25 10.22 20.85 48.63
Price-to-Free Cash Flow (P/FCF) Ratio
72.39 22.30 37.20 36.47 29.39
Price-to-Operating Cash Flow Ratio
56.19 19.21 31.08 30.61 26.70
Price-to-Earnings Growth (PEG) Ratio
1.45 0.44 1.62 21.24 0.56
Price-to-Fair Value
7.29 7.25 10.22 20.85 48.63
Enterprise Value Multiple
22.00 16.38 22.92 15.01 32.50
Enterprise Value
50.80B 29.14B 27.63B 14.09B 21.91B
EV to EBITDA
22.00 16.38 22.92 15.01 32.50
EV to Sales
9.17 8.27 11.68 9.08 18.40
EV to Free Cash Flow
67.08 20.54 35.49 24.25 28.91
EV to Operating Cash Flow
55.05 17.69 29.66 20.35 26.26
Tangible Book Value Per Share
7.11 4.45 2.90 1.04 0.45
Shareholders’ Equity Per Share
7.10 4.45 2.90 1.04 0.46
Tax and Other Ratios
Effective Tax Rate
0.16 0.17 0.15 0.15 0.15
Revenue Per Share
5.53 3.59 2.42 1.59 1.20
Net Income Per Share
2.06 1.48 1.03 0.85 0.83
Tax Burden
0.84 0.83 0.85 0.85 0.85
Interest Burden
1.08 1.00 1.00 1.00 1.20
Research & Development to Revenue
0.02 0.02 0.02 0.02 0.01
SG&A to Revenue
0.03 0.03 0.05 0.01 <0.01
Stock-Based Compensation to Revenue
0.02 <0.01 <0.01 0.01 <0.01
Income Quality
0.45 0.94 0.79 0.71 0.86
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis